ICMR – NIHR
All Publications
सभी प्रकाशन
A searchable index of every scientist-authored publication
Filter / फ़िल्टर:
| # | Title शीर्षक | Year वर्ष | Scientist वैज्ञानिक | Link देखें |
|---|---|---|---|---|
| 471 |
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 472 |
Challenges, Barriers and Good Practices in the Implementation of Rashtriya Bal Swasthya Karyakram (RBSK) in Jodhpur
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 473 |
Challenges, barriers, and good practices in the implementation of Rashtriya Bal Swasthya Karyakram in Jodhpur, India.
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 474 |
Clinical features and mortality in COVID-19 SARI versus non COVID-19 SARI cases from Western Rajasthan, India
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 475 |
COVID-19 appropriate behavior in India: Time to invest for the benefits in future.
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 476 |
COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 477 |
COVID-19 vaccine hesitancy among medical students in India.
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 478 |
COVID-19 vaccine hesitancy among undergraduate medical students: results from a nationwide survey in India
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 479 |
Developing a health-promoting school using knowledge to action framework
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
| 480 |
Efficacy and safety of ayurveda intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections–an open labelled, parallel group, randomized controlled clinical trial.
|
2021 |
Prof. (Dr.) Pankaj Bhardwaj
प्रो. (डॉ.) पंकज भारद्वाज
Director
निदेशक
|
View |
Showing 471–480
of 643 publications /
कुल 643 प्रकाशनों में से 471–480 दिखा रहे हैं